Attend our Symposium during the ASPIRE 2018 Scientific Programme

Date & Time:13 April, Friday, 3:30pm - 5:10pm
Venue:Plenary Hall, Taipei International Convention Center, Taiwan.

Join our speakers from around the global and explore topics from carrier screening to postnatal screening. Explore different stages of reproductive health and genetic analysis methods that can help provide you more information.

Attend our symposium and discover the exciting and fast accelerating field of genetic analysis.

Comprehensive Genetic Analysis Methods in Reproductive Health

Symposium Agenda

The New Era of Aneuploidy Testing in IVF: Trophectoderm Biopsy and NGS
By Carmen Garcias, Molecular Biologist (Igenomix, Spain)

Carmen García received her Bachelor´s degree in Biology and a PhD in Biotechnology at the University of Valencia. She also has a Master degree in Human Assisted Reproduction at Instituto Universitario IVI (Valencia, Spain).

She also has an extensive experience in the study of chromosomal abnormalities in embryos using NGS (Next-Generation Sequencing) technology at the Preimplantation Genetic Screening Laboratory placed in Igenomix (Valencia, Spain). She was also lab manager of IGENOMIX México for more than a year.

At present, she is working in Igenomix Valencia in the PGS research department.
Merging Sequencing and Structural Variant Analysis into A Single Preconception Expanded Carrier Screening Research Assay
By Doron M. Behar, CEO (igentify, Israel)

Doron M. Behar, serves as the CEO of igentify, LTD, and as the Chief Scientist Officer at Gene By Gene, LTD. Dr. Behar holds an MD and PhD degrees from the Technion – Israel Institute of Technology.

Dr. Behar has multi-year background experience in the development of genetic testing for the public using a direct internet based customer approach at his capacity as the chief science officer of Gene by Gene Ltd. His primary interest is in developing robust, low-priced genetic testing to the general public that will allow the hope of responsible personalized genetic medicine to any individual worldwide.
Chromosomal Microarray in Prenatal Diagnosis
By Yi-Hui Lin, Medical Director (GGA, Taiwan)

Dr. Yi-Hui Lin obtained her medical degree at Chang Gung University in Taoyuan, Taiwan. Her residency training of Obstetrics and Gynecology was at Mackay Memorial Hospital, and she completed her fellowship at Mackay Memorial Hospital in clinical cytogenetics and prenatal diagnosis.

She is currently the medical director of Genesis Genetics Asia (GAA) Laboratory supervising pre- and post-natal chromosomal microarray (CMA) analysis and preimplantation genetic screening by CMA and Next Generation Sequencing (NGS) since 2012. She is a member of the genetic counseling team of GGA Corp. and devotes herself to pre- and post-test counseling.
Simultaneous PGT-A and PGT-M with Next Generation Sequencing
By Luis A. Alcaraz, Co-Founder and Lab Director (Bioarray, Spain)

Luis is technical manager and co-founder of Bioarray. He developed his scientific career in different fields related to molecular biology, from gene sequencing to drug discovery, but always with a strong interest in bioinformatics. He obtained his PhD degree in proteomics. During his postdoc, he changed the course of his research to developing biosensors, working in a project to detect biomarkers in the culture media of human embryo related to aneuploidy. At the same time, he funded Bioarray with Andrés Antón. From this moment, Luis has been working passionately in microarrays and next generation sequencing applied to genetic diagnosis.
Register and redeem an unique lanyard with Duo Charging Cable.
Redeem now ›

Visit our booth #B04 on 13 to 15 April.
Learn about our latest products and applications over a lovely cup of Bubble Tea. Explore different genetic analysis methods in the various stages of the reproductive health and stand a chance to win exclusive prizes at our booth.

Don’t forget to register your interest in our symposium and redeem an exclusive lanyard with duo charging cable! While stock lasts.

*Entry to ASPIRE 2018 will require an ASPIRE2018 delegate pass.